優刻得(688158.SH):定增募資額擬由不超20億元調至不超19.65億元
格隆匯 12 月 8日丨優刻得(688158.SH)公佈,2020年12月8日,公司召開第一屆董事會第十八次會議及第一屆監事會第十次會議,審議通過了《關於調整公司本次向特定對象發行股票方案的議案》等相關議案。鑑於公司存在新投入或擬投入的財務性投資共計3500萬元,該財務性投資擬從本次發行募集資金總額中扣除。根據公司實際情況及本次發行的進展情況,公司擬調整本次發行方案,募集資金總額由不超過人民幣20億元(含本數)調整為不超過人民幣19.65億元(含本數)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.